{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:41:07Z","timestamp":1760276467888,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jjcc.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T23:41:20Z","timestamp":1518738080000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy"],"prefix":"10.1016","volume":"72","author":[{"given":"Wataru","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Toba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Osue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuari","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Yasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2018.01.006_bib0170","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0175","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0180","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1253\/circj.CJ-66-0065","article-title":"Guidelines for elective percutaneous coronary intervention in patients with stable coronary artery disease (JCS 2011) published in 2012-digest version","volume":"77","author":"JCS Joint Working Group","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0185","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0190","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","article-title":"Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial","volume":"54","author":"Nicolsky","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0195","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"Am J Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0200","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jjcc.2016.07.021","article-title":"Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a meta-analysis","volume":"69","author":"Basaraba","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0210","first-page":"720","article-title":"Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent","volume":"84","author":"Toledano Delgado","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2012.08.037","article-title":"Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography","volume":"111","author":"Kim","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0220","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehu026","article-title":"Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation","volume":"35","author":"Silber","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0225","first-page":"1735","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk score from PARIS","volume":"315","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0230","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on Thrombosis and Safety (GRADITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0235","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0240","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1253\/circj.CJ-12-0476","article-title":"Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in Japanese patients receiving clopidogrel","volume":"76","author":"Nishio","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0245","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0250","doi-asserted-by":"crossref","first-page":"e002223","DOI":"10.1161\/CIRCINTERVENTIONS.114.002223","article-title":"Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis","volume":"8","author":"Piccolo","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0255","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jjcc.2016.08.015","article-title":"Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: the landmark analysis from Tokyo-MD PCI registry","volume":"69","author":"Ueshima","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis. Findings from optical coherence tomography and intravascular ultrasound imaging","volume":"5","author":"Guagliumi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0265","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0270","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analyzed by optical coherence tomography: insights from the national PESTO French registry","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0275","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0280","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/eurheartj\/ehs318","article-title":"Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials","volume":"33","author":"Cassese","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0285","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention","volume":"66","author":"G\u00e9n\u00e9reux","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0290","first-page":"972","article-title":"Frequency and risk of non-cardiac surgery after drug-eluting stent implantation","volume":"77","author":"Gandhi","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0295","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(03)00622-3","article-title":"Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting","volume":"42","author":"Wilson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0300","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.injury.2016.06.019","article-title":"The older they are the harder they fall: injury patterns and outcome by age after ground level falls","volume":"47","author":"Bhattacharya","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.CIR.86.3.723","article-title":"Migration of smooth muscle and endothelial cells: critical events in restenosis","volume":"86","author":"Casscells","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0310","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0735-1097(96)00417-2","article-title":"Role of platelets in restenosis after percutaneous coronary revascularization","volume":"28","author":"Le Breton","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0315","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2017.04.108","article-title":"Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model","volume":"240","author":"Kim","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0320","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/clc.22575","article-title":"Similar impact of clopidogrel or ticagrelor on carotid atherosclerotic plaque inflammation","volume":"39","author":"Oh","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0325","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2017.01.155","article-title":"Relationship between quantities of tissue prolapse after percutaneous coronary intervention and neointimal hyperplasia at follow-up on serial optical coherence tomography examination","volume":"241","author":"Sugiyama","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2018.01.006_bib0330","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.114.014704","article-title":"Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry","volume":"132","author":"Soeda","year":"2015","journal-title":"Circulation"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718300182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718300182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:58:54Z","timestamp":1760273934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508718300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0914508718300182"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.01.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}